Atropos Health, working in the field of data, received an investment of 33 million dollars

Working in data field Atropos Health, $33 million received investment. The company’s B series investment round Valtruis directed. In the investment round of US-based Atropos Health Breyer Capital, Emerson Collective, Presidio Ventures, Cencora Ventures, McKesson Ventures ve Merck GHI Fund took place. Atropos Health will use the new investment to develop its generative AI capabilities and expand into markets such as Japan and Brazil.

Atropos Health in 2020 Saurabh Gombar, Nigam Shah ve Brigham Hyde was founded by The company stands out as a company that develops artificial intelligence-supported solutions using real-world data (RWD) and real-world evidence (RWE) to improve decision-making processes in healthcare. The company provides its users with access to the data of more than 200 million patients.

Atropos Health has developed a platform that analyzes large amounts of health data and makes it available for clinical decisions. The company’s technology helps doctors guide treatment decisions by providing fast and reliable answers to their clinical questions. Atropos Health has developed an operating system called Geneva OS that enables monitoring studies to be produced quickly and at large scale. ChatRWD, which is a part of this system, is known as an artificial intelligence-supported chat interface.

ChatRWD is actually a chatbot driven by the big language model. The product is used to answer clinical questions and generate observational study reports. Company; Janssen Research & Development, Cencora It cooperates with companies such as.